Initial experience with the AbioCor implantable replacement heart system

Dowling, Robert D.; Gray, Laman A.; Etoch, Steven W.; Laks, Hillel; Marelli, Daniel; Samuels, Louis E.; Entwistle, John W.; Couper, G.S.; Vlahakes, Gus J.; Frazier, O.H.

doi:10.1016/j.jtcvs.2003.07.023

Cited by 164 publications

(78 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[30]  Consumer Electronics -devices using induction to charge portable consumer electronics such as cell phones. [31]  Recharging electric cars/buses  Sealless Valve-inductive(wireless) energy transfer via a pipe wall (this thesis)…”

Section: Short Distance Applicationsmentioning

confidence: 99%

An Inductive Power Transfer through metal object

Imoru

Jassal

Polinder

et al. 2013

2013 1st International Future Energy Electronics Conference (IFEEC)

View full text Add to dashboard Cite

Section: Short Distance Applicationsmentioning

confidence: 99%

An Inductive Power Transfer through metal object

Imoru

Jassal

Polinder

et al. 2013

2013 1st International Future Energy Electronics Conference (IFEEC)

View full text Add to dashboard Cite

“…Three died in the perioperative period from hemorrhage (n = 2) or air embolism (n = 1), and six patients died from multiorgan failure within the first 9 months. The remaining five patients survived for 9-15 months but died from complications related to stroke, infection, or organ failure, except the longest surviving patient, in whom the device failed because an internal flexible membrane ruptured [8]. While ABIOMED subsequently refined the device to decrease the overall size and the US FDA approved the refined device for use in humans, the project was deemed commercially unviable and prohibitively difficult and was discontinued in 2007.…”

Section: The Beginnings Of Tah Technologymentioning

confidence: 99%

Previous challenges and current progress–the use of total artificial hearts in patients with end-stage heart failure

Goerlich¹,

Frazier²,

Cohn³

2016

Expert Review of Cardiovascular Therapy

View full text Add to dashboard Cite

“…Several patients have received the device, and reports of initial experiences have appeared. 47 The Cardiowest Total Artificial heart was recently approved by the FDA as a bridge to transplantation in patients in need of biventricular support. 48 This is a biventricular, pneumatic, pulsatile pump that totally replaces the native ventricles and all 4 cardiac valves.…”

Section: Total Artificial Heartsmentioning

confidence: 99%

Mechanical Device–Based Methods of Managing and Treating Heart Failure

Mancini

Burkhoff

2005

Circulation

View full text Add to dashboard Cite

Abstract-Despite advances in pharmacological treatments aimed at neurohormonal blockade for heart failure in the setting of left ventricular pump dysfunction, there is still a growing number of patients with advanced symptoms who suffer significant morbidity and mortality. Mechanical stresses and chronic neurohormonal activation conspire to propagate maladaptive ventricular remodeling responsible for the insidious nature of this disease. Recent studies suggest that further pharmacological neurohormonal blockade may not be safe or effective, which has driven development of devices for this patient population. Furthermore, such devices may target fundamental pathophysiological abnormalities that are largely hemodynamic and mechanical in nature that are not addressed by available pharmacological agents. The profound reverse remodeling routinely associated with left ventricular assist device use, reviewed in detail, further validates device-based approaches and should inspire research to find ways to make this recovery more complete and permanent. Accordingly, this review focuses on the multitude of mechanical device-based approaches currently being investigated to manage and treat this population. From devices for monitoring patient status to anticipate congestive heart failure exacerbations and preemptively adjust therapy to devices to support preterminal patients with end-stage disease, it is recognized that these device-based approaches will assume an increasingly important role in treating the growing number of patients with advanced heart failure. (Circulation. 2005;112:438-448.)

show abstract

Initial experience with the AbioCor implantable replacement heart system

Abstract: The initial clinical experience suggests that the AbioCor might be effective therapy in patients with advanced biventricular failure. There have been no significant device malfunctions. Two of these patients have been discharged from the hospital.

Cited by 164 publications

References 23 publications

An Inductive Power Transfer through metal object

An Inductive Power Transfer through metal object

Previous challenges and current progress–the use of total artificial hearts in patients with end-stage heart failure

Mechanical Device–Based Methods of Managing and Treating Heart Failure

Contact Info

Product

Resources

About